CN112094274A
|
|
Improved tofacitinib synthesis method and impurity preparation method
|
CN112111408A
|
|
Micafungin precursor WF11899A production strain and fermentation method
|
CN111721858A
|
|
Method for determining genotoxic impurities in rivaroxaban
|
CN111487334A
|
|
Detection method of low-limit canagliflozin impurities
|
CN111407730A
|
|
Pharmaceutical composition containing linagliptin
|
CN111349077A
|
|
Pyridazine derivative and preparation method and medical application thereof
|
CN111116688A
|
|
Preparation method of prazazolmitrin
|
CN111138437A
|
|
Substituted pyrazolo [1,5-a ] pyrimidine amino acid derivatives and uses thereof
|
CN111537622A
|
|
Impurities of heterocyclic boronic acid compounds and detection methods
|
CN111533675A
|
|
Impurities of heterocyclic boronic acid compounds and methods of controlling the same
|
CN111540417A
|
|
Crystal form quantification method of canagliflozin
|
CN111057049A
|
|
Preparation method of canagliflozin hemihydrate
|
CN110698468A
|
|
Preparation method of canagliflozin
|
CN110584096A
|
|
Hirsutella sinensis fermentation liquid enzyme and preparation method thereof
|
CN110585159A
|
|
Tablet containing sirolimus
|
CN110496141A
|
|
A kind of pharmaceutical composition containing cordyceps sinensis
|
CN110183502A
|
|
A kind of feldamycin impurity and preparation method thereof
|
CN110037992A
|
|
A kind of stable feldamycin composition
|
CN110037991A
|
|
Stable China advanced in years is for Buddhist nun's pharmaceutical composition and preparation method thereof
|
CN109568275A
|
|
A kind of freeze-dried composition and preparation method thereof containing caspofungin acetate
|